World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
58003
World Ranking
11492
National Ranking
5890

Overview

Philip Raskin is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research primarily focuses on the field of Medicine, with specific expertise in Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Physiology, and Pathology and Forensic Medicine.

Their work covers a broad range of topics centered on diabetes and metabolism, including:

  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Vitamin D Research Studies
  • Diet and metabolism studies
  • Metabolism, Diabetes, and Cancer

Philip Raskin has contributed to multiple research papers, some of which have attracted notable attention in important medical journals. Selected recent publications include:

  • Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes, 2022, published in New England Journal of Medicine
  • Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial, 2021, published in The Lancet Diabetes & Endocrinology
  • Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial, 2023, published in Diabetes Care
  • Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes, 2021, published in The Journal of Clinical Endocrinology & Metabolism
  • IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes, 2021, published in JCI Insight

The scientist's work has been frequently published in the following venues:

  • Diabetes Care
  • The Journal of Clinical Endocrinology & Metabolism
  • New England Journal of Medicine
  • European Journal of Clinical Nutrition
  • Diabetes

Throughout their career, Philip Raskin has collaborated extensively with other researchers. Frequent co-authors include Jeffrey P. Krischer, Anastassios G. Pittas, Carla J. Greenbaum, Neda Rasouli, and Ranee Chatterjee.

Best Publications

  • Report of the expert committee on the diagnosis and classification of diabetes mellitus

    James R. Gavin;K. G M M Alberti;Mayer B. Davidson;Ralph A. DeFronzo

  • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    David M. Nathan;Patricia A. Cleary;Jye Yu C Backlund;Saul M. Genuth

  • Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    Pablo E. Pergola;Philip Raskin;Robert D. Toto;Colin J. Meyer

  • Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

    George L. Bakris;George L. Bakris;George L. Bakris;Vivian Fonseca;Vivian Fonseca;Richard E. Katholi;Richard E. Katholi;Janet B. McGill

  • Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Philip Raskin;Elsie Allen;Priscilla Hollander;Andrew Lewin

  • Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

    Y. Harati;C. Gooch;M. Swenson;S. Edelman

  • Treatment of hypertension in adults with diabetes.

    Carlos Arauz-Pacheco;Marian A. Parrott;Philip Raskin

  • Cardiac Steatosis in Diabetes Mellitus A 1H-Magnetic Resonance Spectroscopy Study

    Jonathan M. McGavock;Ildiko Lingvay;Ivana Zib;Tommy Tillery

  • Hyperglycemia and Acute Coronary Syndrome A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism

    Prakash Deedwania;Mikhail Kosiborod;Eugene Barrett;Antonio Ceriello

  • Vitamin D Supplementation and Prevention of Type 2 Diabetes

    Anastassios G Pittas;Bess Dawson-Hughes;Patricia Sheehan;James H Ware

  • Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensors

    C. P. Quinn;M. V. Pishko;D. W. Schmidtke;M. Ishikawa

  • Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus

    Sherwyn Schwartz;Philip Raskin;Vivian Fonseca;Jane F. Graveline

  • Somatostatinoma syndrome. Biochemical, morphologic and clinical features.

    G. J. Krejs;L. Orci;J. M. Conlon;M. Ravazzola

  • A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes

    Philip Raskin;Marc Rendell;Matthew C. Riddle;Jo F. Dole

  • The Treatment of Hypertension in Adult Patients With Diabetes

    Carlos Arauz-Pacheco;Marian A. Parrott;Philip Raskin

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

    Antoinette Moran;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Treatment of Hypertension in Adults With Diabetes

    Philip Raskin

Frequent Co-Authors

Roger H Unger
Roger H Unger The University of Texas Southwestern Medical Center
Janet B. McGill
Janet B. McGill Washington University in St. Louis
Jay S. Skyler
Jay S. Skyler University of Miami
Neil H. White
Neil H. White Washington University in St. Louis
George L. Bakris
George L. Bakris University of Chicago
John E. Gerich
John E. Gerich Mayo Clinic
John M. Lachin
John M. Lachin George Washington University
Vivian Fonseca
Vivian Fonseca Tulane University
Desmond A. Schatz
Desmond A. Schatz University of Florida
Trevor J. Orchard
Trevor J. Orchard University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine, there are other rewarding careers and flexible degree options to consider. Many students choose supportive healthcare roles that can be started or advanced through online study. For example, online healthcare administration programs prepare graduates for management positions in hospitals, clinics, and insurance companies, often without the need for a medical degree.

Aspiring healthcare leaders can also consider an affordable mha online to further their careers in administration with greater flexibility and lower costs. For nurses aiming for the highest levels of clinical practice, the best online bsn to dnp programs offer a direct path to a doctorate, while enabling working professionals to study at their own pace.

Those interested in pharmacy careers may explore the 3-year online pharmd, which allows students to earn their Doctor of Pharmacy degree online more quickly than traditional programs. These pathways provide alternative routes to leadership, research, and specialized clinical roles in healthcare.

Best Scientists Citing Philip Raskin

Trending Scientists

Recently Published Articles